Open Conversations: Pathway to Launch Excellence It is widely acknowledged that yesterday’s playbook no longer provides the best blueprint for launching tomorrow’s medicines.
Open Conversations: Pathway to Launch Excellence It is widely acknowledged that yesterday’s playbook no longer provides the best blueprint for launching tomorrow’s medicines.
How the smart combination of domain expertise, data analytics and technology is transforming the development and commercialization of medicines
From mobile technology to the Internet of Things, virtual reality to decision-making supercomputers, technology continues to rapidly move from the fringes of practice to the medical mainstream.
McCann Complete Medical outlines why multichannel communications - anchored in strong clinical data from journal publications - must not only be transparent, they must also provide a clear clinical context for local HCPs.
Across Europe there are considerable challenges in clearing the ‘fourth hurdle’, with healthcare technology assessment in a number of key markets facing change and uncertainty.
On 22 February 2016, Merck Consumer Health organised the first annual Global Consumer Health Debate at the company’s global headquarters in Darmstadt, Germany, focusing on the health and well-being challenges of women in different cultures and at different life stages.
Tracking the evolving relationship between patient, physician and pharma, beginning with the digital patient and looking at European plans for EU citizens to have access to online prescribing, electronic health records and digital health applications to improve patient care and outcomes.
Six benefits of working agency-side… and three questions to ask
Turning big data to information and information to insight, a McCann Complete Medical supplement
In September a special PME supplement took aim at the industry’s challenges in pricing, value and access in the UK, providing practical advice on navigating the HTA process, communicating your value proposition to payers and demonstrating value in the real world.
通信模型——所以为什么parts of the pharmaceuticals industry stuck in the dark ages when it comes to adopting a truly multichannel approach in the pre-launch phase?
Working closely with, and being attuned to the needs of, patients remains just as valid as when that near-ubiquitous term ‘patient-centricity’ was first coined
Pharmaceutical executives that fail to understand the full extent of their compliance obligations could be sleepwalking their way towards major reputational damage
No results were found
We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...
